beta
/319. Discovery and Development of ITI-1549: A Novel Serotonin 5-HT2A Agonist, Non-Hallucinogenic Neuroplastogen, for the Treatment of Neuropsychiatric Disorders
Abstract

Abstract N/A

RelatedView All
Authors 9View All
CitationsView All
Citing-
Cited By-